{
    "organizations": [],
    "uuid": "cbe2362ff388087f1021f7857f272c5ea65cf4ef",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-poxel-and-roivant-announce-strateg/brief-poxel-and-roivant-announce-strategic-agreement-for-development-and-commercialization-of-imeglimin-idUSFWN1Q208N",
    "ord_in_thread": 0,
    "title": "BRIEF-Poxel And ‍Roivant Announce Strategic Agreement For Development And Commercialization Of Imeglimin",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 12 (Reuters) - POXEL SA:\n* ‍ROIVANT AND POXEL ANNOUNCE STRATEGIC AGREEMENT FOR DEVELOPMENT AND COMMERCIALIZATION OF IMEGLIMIN IN U.S., EUROPE, AND ADDITIONAL COUNTRIES WORLDWIDE​\n* ‍ROIVANT TO CONCURRENTLY INVEST $15 MILLION (APPROXIMATELY EUR 12 MILLION) IN POXEL THROUGH SUBSCRIPTION TO NEWLY-ISSUED ORDINARY SHARES AT EUR 8.5 PER SHARE​\n* ‍TO RECEIVE UPFRONT PAYMENT OF $35 MILLION​ * ‍POXEL TO CONTRIBUTE $25 MILLION (APPROXIMATELY EUR 20 MILLION) TO DEVELOPMENT PROGRAM​\n* ‍ROIVANT WILL BE RESPONSIBLE FOR IMEGLIMIN‘S DEVELOPMENT AND COMMERCIALIZATION IN U.S., EUROPE, AND OTHER COUNTRIES OUTSIDE OF POXEL‘S PARTNERSHIP WITH SUMITOMO DAINIPPON PHARMA​\n* ‍TO RECEIVE UPFRONT PAYMENT OF $35 MILLION, POTENTIAL FUTURE DEVELOPMENT AND REGULATORY MILESTONE PAYMENTS AND SALES-BASED PAYMENTS OF UP TO $600 MILLION, AND DOUBLE-DIGIT ROYALTIES ON NET SALES​\n* ‍PARTIES WILL DECIDE ON A POTENTIAL CO-PROMOTION PRIOR TO COMMERCIALIZATION​\n* ‍POXEL TO RECEIVE UPFRONT PAYMENT OF $35 MILLION, POTENTIAL FUTURE DEVELOPMENT AND REGULATORY MILESTONE PAYMENTS AND SALES-BASED PAYMENTS OF UP TO $600 MILLION, AND DOUBLE-DIGIT ROYALTIES ON NET SALES​\n* SEES THE INITIATION OF PHASE 3 PROGRAM IN U.S. AND EUROPE IN 2019​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-12T15:12:00.000+02:00",
    "crawled": "2018-02-13T15:41:00.025+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "poxel",
        "sa",
        "poxel",
        "announce",
        "strategic",
        "agreement",
        "development",
        "commercialization",
        "imeglimin",
        "europe",
        "additional",
        "country",
        "concurrently",
        "invest",
        "million",
        "approximately",
        "eur",
        "million",
        "poxel",
        "subscription",
        "ordinary",
        "share",
        "eur",
        "per",
        "receive",
        "upfront",
        "payment",
        "contribute",
        "million",
        "approximately",
        "eur",
        "million",
        "development",
        "responsible",
        "imeglimin",
        "development",
        "commercialization",
        "europe",
        "country",
        "outside",
        "poxel",
        "partnership",
        "sumitomo",
        "dainippon",
        "receive",
        "upfront",
        "payment",
        "million",
        "potential",
        "future",
        "development",
        "regulatory",
        "milestone",
        "payment",
        "payment",
        "million",
        "royalty",
        "net",
        "decide",
        "potential",
        "prior",
        "receive",
        "upfront",
        "payment",
        "million",
        "potential",
        "future",
        "development",
        "regulatory",
        "milestone",
        "payment",
        "payment",
        "million",
        "royalty",
        "net",
        "see",
        "initiation",
        "phase",
        "program",
        "europe",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}